Erythropoietin dosing regimen for treating anemia

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01)

Patent

CA 2468499

The present invention provides a new subcutaneous injection dosing regimen for erythropoietin to treat anemia. The new erythropoietin treatment regimen of the present invention results in improved hemoglobin levels with less frequent dosing.

La présente invention concerne un nouveau schéma de dosage d'injection sous-cutanée d'érythropoïétine pour traiter l'anémie. Ledit nouveau schéma de traitement par érythropoïétine selon la présente invention permet d'obtenir des niveaux d'hémoglobine améliorés avec un dosage moins fréquent.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Erythropoietin dosing regimen for treating anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin dosing regimen for treating anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin dosing regimen for treating anemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1582890

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.